$300 million raised for COVAX vaccine sharing at GAVI event: US

The US will contribute an additional $2 billion to the vaccines alliance Gavi through 2022

Topics
Coronavirus Vaccine | US funding

Reuters 

Coronavirus vaccine, covid-19, vaccination
Representative image

A fund-raising event organised by the Gavi vaccine alliance and the United States secured more than $300 million in fresh funds and Covid-19 doses for the COVAX vaccine-sharing facility, USAID Acting Administrator Gloria Steele said on Thursday.

"Investment in COVAX is a prerequisite for recovery ...ending the acute phase of the pandemic is currently the best economic decision for any country," Jose Manuel Barroso, chair of the Gavi vaccine alliance, said after the three-hour event hosted by the organisation.

US to contribute $2 billion

The US will contribute an additional $2 billion to the vaccines alliance Gavi through 2022 in support of the global COVAX initiative so that people everywhere can have access to safe and effective vaccines, Secretary of State Antony Blinken announced on Thursday and called on partners to aid urgent vaccine manufacturing, supply and delivery needs.

"It will contribute an additional $2 billion to this effort through 2022, because people everywhere should have access to rigorously tested, safe, and effective Covid- 19 vaccines," Blinken said.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Thu, April 15 2021. 23:08 IST
RECOMMENDED FOR YOU